In summary, these studies reveal that iNKT and other CD1d-expressing or CD1d restricted cells, which include type II NKT cells impact lipid and lipoprotein levels and the initiation and progression of atherosclerosis in a complex site-specific manner and in some cases gender specific manner. The gene discussed is CD1D; the disease is atherosclerosis.